Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 11, 2017 - Issue
Submit an article Journal homepage
119
Views
23
CrossRef citations to date
0
Altmetric
Review

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date

Aleksander Lenert1 Division of Rheumatology, University of Kentucky, Kentucky Clinic, Lexington, KYCorrespondence[email protected]
,
Timothy B Niewold2 Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN
&
Petar Lenert3 Division of Immunology, Department of Internal Medicine, The University of Iowa, Iowa City, IA, USA
Pages 747-757 | Published online: 13 Mar 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.